Skip to content
You are now leaving https://www.ionispharma.com to visit

Ionis to Present Inotersen NEURO-TTR Phase 3 Study Results at 1st European ATTR Amyloidosis Meeting

Company to host webcast conference call on Thursday, November 2 at 7:00 a.m. Eastern Time CARLSBAD, Calif. , Nov. 1, 2017 /PRNewswire/ —  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Thursday, November 2 at 7:00 a.m.